Life Stem Genetics Inc. (LIFS)

Market Cap	49.17K
Revenue	n/a
Net Income	n/a
Shares Out	245.84M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	980
Average Volume	2,842
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0002
Beta	1,215.12
RSI	44.39
Earnings Date	n/a

About Life Stem Genetics

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborativ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2012
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: LIFS